Example: tourism industry
4. Medication Adherence Interventions: Comparative ...
costs.3, 5,17-20 Strong evidence suggests that benefits attributable to improved self-management of chronic diseases could result in a cost-to-savings ratio of approximately 1:10.21-27 Evidence Report/Technology Assessment Number 208 4. Medication Adherence Interventions: Comparative Effectiveness
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
Evidence-based Practice Center Systematic Review Protocol ...
effectivehealthcare.ahrq.govWhat is the effect of vitamin D intake or combined vitamin D plus calcium intake (but not calcium intake alone) on clinical outcomes, including cardiovascular diseases, cancer, immune function, pregnancy or birth outcomes, mortality, fracture, renal outcomes, and soft tissue
Diagnosis and Management of Gout: Current State of the ...
effectivehealthcare.ahrq.govAllopurinol Nausea, upset stomach, diarrhea, and elevated liver enzymes Rare but serious adverse effects include toxic epidermal necrolysis (TEN), Stevens-Johnson syndrome (SJS), bone marrow suppression, and drug rash with eosinophilia and systemic symptoms (DRESS) syndrome. Febuxostat
Medication-Assisted Treatment Models of Care for …
effectivehealthcare.ahrq.govquality of care; and use of Internet-based learning networks. Most trials of MAT in primary care settings focus on comparisons of one pharmacological therapy versus another, or on the effectiveness of different intensities or types of psychosocial interventions, rather than on
Attention Deficit Hyperactivity Disorder: Diagnosis and ...
effectivehealthcare.ahrq.govAttention Deficit Hyperactivity Disorder: Diagnosis and Treatment in Children and Adolescents Structured Abstract Objectives. Attention deficit hyperactivity disorder (ADHD) is a common pediatric neurobehavioral disorder often treated in the primary care setting. This systematic review
Your path to good P A W S Good Health health begins with ...
effectivehealthcare.ahrq.govFollow Your Path to Good Health . 1. Visit your health care provider for an evaluation on your condition. 2. Decide what treatment path is best for you. Your health care provider will help you ... PAWS Team Subject: Prescription for Antibiotics, Wait and See, Ear Infection
Slide 1 Engaging Stakeholders in the Effective Health Care ...
effectivehealthcare.ahrq.govlearning tool “Engaging Stakeholders in the Effective Health Care Program” to provide researchers and investigators with foundational information on, and tools for, engaging a broad range of stakeholders in the Effective Health Care Program.
Vitamin D and Calcium: A Systematic Review of Health ...
effectivehealthcare.ahrq.govVitamin D and Calcium: A Systematic Review of Health Outcomes (Update) Executive Summary. 2 concentrations and between 25(OH)D concentrations, and several health outcomes. Throughout the remainder of this summary and in the report, new text is presented in boldface type.
Assessment Tools for Palliative Care
effectivehealthcare.ahrq.govTechnical Brief Number 30 . Assessment Tools for Palliative Care . Prepared for: Agency for Healthcare Research and Quality . U.S. Department of Health and Human Services
Strategies to De-escalate Aggressive Behavior in ...
effectivehealthcare.ahrq.govSuggested citation: Gaynes BN, Brown C, Lux LJ, Brownley K, Van Dorn R, Edlund M, Coker-Schwimmer E, Zarzar T, Sheitman B, Palmieri Weber R, Viswanathan M, Lohr KN. Strategies To De-escalate Aggressive Behavior in Psychiatric Patients. Comparative Effectiveness Review No. 180. (Prepared by the RTI-UNC Evidence-based Practice Center
Resident Safety Practices in Nursing Home Settings
effectivehealthcare.ahrq.govnursing home residents, whose vulnerability and complexity make them markedly different from most hospital patients. Future research needs include defining safety in the nursing home context, which differs considerably from that of hospitals. Defining safety must take into account
Related documents
Risk Assessment and Tools for Identifying Patients at High ...
www.acep.orgclinicians in assessing the risk of violence in patients being considered for discharge. It creates a percentage of likelihood that violence will be committed in the next several months. This is a product that must be purchased for use. 3. Historical Clinical Risk-20 (HCR-20) is divided into three sections historical, clinical, and risk management.
Historical-Clinical-Risk Management-20, Version 3 (HCR-20 ...
www.antoniocasella.euHistorical-Clinical-Risk Management-20, Version 3 (HCR-20V3): Development and Overview Kevin S. Douglas Department of Psychology, Simon Fraser University, Burnaby, Canada; Department of Social Sciences, Mid-Sweden University, Sundsvall, Sweden Stephen D. Hart Department of Psychology, Simon Fraser University, Vancouver, British Columbia, Canada
Clinical risk management in general practice
www.racgp.org.auClinical risk management in general practice iii A quality and safety improvement guide and educational resource for individual- or group-based learning Acknowledgements The generous contributions of many people have enabled development of this …
Coronavirus (COVID-19)
www.dhhs.vic.gov.auHigh risk See sections Priority groups and settings Historical case Defined in section Historical case Incubation period Period of time between exposure to the disease and the onset of symptoms. For COVID-19 likely mean incubation period ~5 days, with range of 1-14 days.
HCR-20 & Violence Risk Assessment” - NASMHPD
nasmhpd.orgRisk assessment instruments predict violence with moderate/large effect sizes › AUC ~ .70 › Among 20 samples, Mdn AUC for SRR = .78 SPJ instruments work as well as actuarial instruments, and perhaps better if used clinically HCR-20 has a strong empirical base across diverse settings, populations Beginning stage of establishing evidence for
Direct Contracting Model: Professional and Global Options ...
innovation.cms.govRisk score greater than 2.0 and less than 3 AND two unplanned hospital admissions in previous 12 months; OR Signs of frailty (e.g., Durable Medical Equipment (DME) claim for hospital bed or transfer equipment). • DCEs caring for one or more specific sub-populations must clearly specify the clinical criteria used
GUIDELINE FOR THE MANAGEMENT OF NAUSEA AND …
www.somanz.orgThe approach to the management of nausea and vomiting in pregnancy (NVP) and hyperemesis gravidarum (HG) in the current era is strongly reminiscent of the cultural attitudes towards the management of pain in labour prior to the introduction of epidural anaesthesia in the 1970s.
Assessment report - European Medicines Agency
www.ema.europa.eupartial response, and survival compared to historical outcomes. Following the CHMP positive opinion on this marketing authorisation, the Committee for Orphan Medicinal Products (COMP) reviewed the designation of Yescarta as an orphan medicinal product in the approved